Examination of the activity of camel milk casein against hepatitis C virus (Genotype-4a) and its apoptotic potential in hepatoma and HeLa cell lines

Hepatitis Monthly

Volumn 11, Issue 9, 2011, Pages 724-730

  Almahdy, Osama ^a   EL Fakharany, Esmail M ^a   EL Dabaa, Ehab ^b   Ng, Tzi Bun ^c   Redwan, Elrashdy M ^a  

^a Universities and Research centers District   (Egypt)

^b THEODOR BILHARZ RESEARCH INSTITUTE   (Egypt)

^c and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

Apoptosis; Blocking; Camel; Casein; Cell entry; Hepatitis C virus

Indexed keywords

ALPHA LACTALBUMIN; CASEIN; MILK PROTEIN;

ANTIVIRAL ACTIVITY; APOPTOSIS; ARTICLE; CAMEL; CELL STRAIN HEPG2; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; ELECTROPHORESIS; GENOTYPE; HELA CELL; HEPATITIS C VIRUS; HEPATOMA CELL; HUMAN; HUMAN CELL; INCUBATION TIME; LEUKOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; TISSUE CULTURE CELL;

EID: 80053639107     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: 10.5812/kowsar.1735143X.1367     Document Type: Article

References (28)

1. Hoofnagle JH. Management of hepatitis C: current and future perspectives. J Hepatol. 1999; 31(Suppl 1):264-8.
2. el-Awady MK, Tabll AA, Redwanel RM, Youssef S, Omran MH, Thakeb F, et al. Flow cytometric detection of hepatitis C virus antigens in infected peripheral blood leukocytes: binding and entry. World J Gastroenterol. 2005; 1133): 5203-8.
3. el-Awady MK, Tabll AA, el-Abd YS, Bahgat MM, Shoeb HA, Youssef SS, et al. HepG2 cells support viral replication and gene expression of hepatitis C virus genotype 4 in vitro. World J Gastroenterol. 2006; 1230): 4836-42.
4. Manns MP, McHutchison JG, Gordon SC, Rustgi VK, Shiffman M, Reindollar R, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet. 2001; 358(9286):958-65.
5. Redwan e-RM, Tabll A. Camel Lactoferrin Markedly Inhibits Hepatitis C Virus Genotype 4 Infection of Human Peripheral Blood Leukocytes. J Immunoassay Immunochem. 2007; 28(3):267-77.
6. El-Fakharany E, Tabll A, El-Wahab A, Haroun B, Redwan E. Potential activity of camel milk-amylase and lactoferrin against hepatitis C virus infectivity in HepG2 and lymphocytes. Hepat Mon. 2008; 8 (2):101-9.
7. El-Fakharany EM, Serour EA, Abdelrahman AM, Haroun BM, Redwan el RM. Purification and characterization of camel (Camelus dromedarius) milk amylase. Prep Biochem Biotechnol. 2009; 39(2):105-23.
8. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry. 1976; 72(1-2):248-54.
9. Redwan E. Simple, sensitive and quick protocol to detect less than 1ng of bacterial lipopolysaccharide. Prep Biochem Biotechnol. 2011; 41(3).
10. Laemmli UK. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4. Nature. 1970; 227(5259):680-5.
11. El-Fakharany EM, Haroun BM, Ng TB, Redwan ER. Oyster Mushroom Laccase Inhibits Hepatitis C Virus Entry into Peripheral Blood Cells and Hepatoma Cells. Protein Pept Lett. 2010; 17(8):1031-9.
12. Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods. 1983; 65(1-2):55-63.
13. NA EL-B, Omar SH, H EL-B, Redwan el RM. Efficacy comparison of gel-based, membrane and glass array techniques to detect human antibodies isotypes among the Egyptian HCV-patients. Hum Antibodies. 2008; 17(3-4):63-71.
14. Ribble D, Goldstein N, Norris D, Shellman Y. A simple technique for quantifying apoptosis in 96-well plates. BMC Biotechnology. 2005; 5:12.
15. Di Bisceglie AM. Hepatitis C. Lancet. 1998; 351(9099):351-5.
16. Lauer GM, Walker BD. Hepatitis C Virus Infection. N Engl J Med. 2001; 345(1):41-52.
17. Swaisgood HE. Chemistry of the caseins. In: Patrick FF, Mc-Sweeney P, editors. Advanced Dairy Chemistry: Proteins. New York: Springer; 2003. p. 139-200.
18. Pellegrini A, Engles M. antiviral compounds derived from naturally occurring. Curr Med Chem. 2005; 4(1):55-66.
19. Clare DA, Catignani GL, Swaisgood HE. Biodefense properties of milk: the role of antimicrobial proteins and peptides. Curr Pharm Des. 2003; 916): 1239-55.
20. Teschemacher H. Opioid receptor ligands derived from food proteins. Curr Pharm Des. 2003; 916): 1331-44.
21. Korhonen H, Pihlanto A. Food-derived bioactive peptides--opportunities for designing future foods. Curr Pharm Des. 2003; 916): 1297-308.
22. Meisel H, Fitz Gerald RJ. Biofunctional peptides from milk proteins: mineral binding and cytomodulatory effects. Curr Pharm Des. 2003; 916): 1289-95.
23. Yamamoto N, Ejiri M, Mizuno S. Biogenic peptides and their potential use. Curr Pharm Des. 2003; 916): 1345-55.
24. Meisel H. Biochemical properties of regulatory peptides derived from mil proteins. Biopolymers. 1997; 43(2):119-28.
25. Svensson M, Duringer C, Hallgren O, Mossberg A, Hakansson A, Linse S, et al. Hamlet-a complex from human milk that induces apoptosis in tumor cells but spares healthy cells. Adv Exp Med Biol. 2002; 503:125-32.
26. Hallgren O, Aits S, Brest P, Gustafsson L, Mossberg AK, Wullt B, et al. Apoptosis and tumor cell death in response to HAMLET (human alpha-lactalbumin made lethal to tumor cells). Adv Exp Med Biol. 2008; 606:217-40.
27. Hakansson A, Zhivotovsky B, Orrenius S, Sabharwal H, Svanborg C. Apoptosis induced by a human milk protein. Proc Natl Acad Sci U S A. 1995; 9217): 8064-8.
28. Gustafsson L, Aits S, Onnerfjord P, Trulsson M, Storm P, Svanborg C. Changes in proteasome structure and function caused by HAMLET in tumor cells. PLoS One. 2009; 4(4):e5229.